A new survey showing huge pay gaps between UK bosses and their staff has found that thecountry’stop 350 company execs are being paid on average 53 times more than their mid-level counterparts.
A poll for the High Pay Centre shared exclusively with The Guardian found that huge salary gaps have become commonplace in large UK businesses and that the majority of Brits did not approve.
It comes as many up and down the country are facing the choice between heating and eating, as energy bills skyrocket and the value of UK pension and out-of-work benefits see the biggest fall in 50 years.
According to the new survey, 63% of workers believe that CEOs shouldn’t be earning more than 10 times that of their staff, and only 3% of people deem it acceptable for them to be paid over 50 times the company’s average wage.
Image: Mutual Interest Media
In reality, research published by the same think tank in 2020 shows many top-level bosses are already being paid 50 times more – with some earning as much as 100 times their company’s median salary.
ADVERTISEMENT
High Pay Research conducted two years ago found a total of 43 bosses of FTSE 350 companies received more than 100 times as much as the average employee, whilst on average bosses are paid at least 53 times more.
It also found that on average an FTSE 100 chief executive makes more money in four days than an average UK worker will over the course of a year.
ADVERTISEMENT
Many respondents felt that policy measures aimed at distributing wealth more evenly could help to raise living standards for people across the UK.
Luke Hildyard, the director of the High Pay Centre, told The Guardian that the research revealed: “the extent to which the lives of those at the top and those of everybody else have become so far removed from each other”.
He added: “That’s probably not a healthy development.
ADVERTISEMENT
Image: PixaHive
“Britain’s biggest employers dedicate a significant amount of their budget to the pay of a small number of top earners.
“Redirecting some of this money to low- and middle-income workers would be a good way to raise living standards and address the cost of living crisis but it will require policymakers and business leaders to be a bit more open-minded about whether those at the top really need to be paid so much.”
Frances O’Grady, the general secretary of the TUC, added: “The whole workforce deserves to share in the success of a firm, not just those in the boardroom. But over the years executive pay has raced ahead of other workers – and now it’s at stratospheric levels.
“It’s time to set a maximum ratio between the top earner in each firm and other workers. There should be workers on remuneration committees, to ground decisions in the interests of the whole workforce.
New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
Emily Sergeant
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
A new daily pill for endometriosis has been approved for use on the NHS, and could help over a thousand women in England every year manage the symptoms of the debilitating condition.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”
Featured Image – Heute
News
Wigan woman jailed after hitting pedestrian in Fiat 500 while driving high on nitrous oxide ‘balloons’
Emily Sergeant
A young woman from Wigan has been handed jail time after hitting a pedestrian while driving high on nitrous oxide.
Louisa Tunstall was driving a white Fiat 500 towards the East Lancashire Road in Wigan at around 7pm on Friday 24 May 2024 – a time when traffic conditions were said to be ‘quiet’ – but Tunstall was under the influence of a now-banned drug, nitrous oxide, at the time of the incident, Greater Manchester Police (GMP) confirmed.
While driving under the influence, 19-year-old Tunstall veered to the left onto the pavement and collided with a 51-year-old woman pedestrian.
After striking the woman, the car then overturned and, in the process, caused serious life-changing injuries.
When questioned by police, Tunstall stated that she ‘took her eyes off the road’ to retrieve something in the footwell before knowing the car had flipped, but she also confirmed that she had just been out to purchase nitrous oxide to use that evening.
After obtaining witness accounts, investigating officers were able to track down nearby CCTV footable which showed Tunstall inhaling nitrous oxide through a balloon whilst driving, seconds before the collision occurred.
#JAILED | It's not a laughing matter when you get behind the wheel under the influence of drugs.
Now Louisa Tunstall has to spend over a year behind bars after inhaling nitrous oxide and causing serious injury in #Wigan last year.
— Greater Manchester Police (@gmpolice) May 14, 2025
Further investigation by GMP’s Forensic Vehicle Examination Unit examined the Fiat 500 and confirmed that no defects were found on the car to contribute towards the collision.
Still to this day, the victim says she is trying to recover from the injuries sustained to her leg that will prevent her from continuing life as she did before.
“The incident is still very raw when I think about it,” the victim explained in her impact statement released by GMP. “I become upset when I think at everything which has been taken away from me and the ongoing affect it has had and continues to have on my daily life.”
GMP says it’s seeing the use of nitrous oxide being a factor in incidents they attend increasing year on year.
Nitrous oxide, also known as ‘laughing gas’, is reported to produce euphoria, relaxation, dizziness, giggling or laughing fits, impaired judgement, and occasionally dissociation and hallucinations – which GMP says affects reaction time and and is ‘likely lead to impairment’ in driving performance, particularly when faced with an unexpected or hazardous situation.
Tunstall appeared at Bolton Crown Court this week, and has been sentenced to one year and eight months imprisonment for having possession of a Class C drug, driving under the influence of drugs, and causing serious injury by dangerous driving.
Alongside being jailed, she was also disqualified from driving for two years and eight months, and has been ordered to take an extended test when she is released.
Georgina Pellant -
3rd May 2022 
